Gabapentin Capsule
Product Images NDC 42385-972

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 42385-972). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Laurus Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Gabapentin Figure1)

Figure 1 (Gabapentin Figure1)
This appears to be a chart or graph related to a clinical trial study. It shows the Maan Pain Score over a period of 8 weeks, split between a 4-week dosage titration period and a 4-week fixed dose period. The study includes a comparison between a placebo and Gabapentin at a dosage of 3600 mg/day. The provided information does not give context on what the Maan Pain Score entails, or the results of the study.*
FDA Label Image

Figure10 (Gabapentin Figure10)

Figure10 (Gabapentin Figure10)
This is a description of a Gabapentin medication. The NDC code for the medicine is 42385-97372. This medication is presented in 100 unit-does capsules with each capsule containing 300 mg of gabapentin USP. There is a medication guide that should be dispensed to each patient. The medicine should be stored at 20° to 25°C. It is manufactured by Laurus Generics and Laurus Labs. The country of origin is India. Dosage and usage information can be found in the package insert.*
FDA Label Image

Figure11 (Gabapentin Figure11)

Figure11 (Gabapentin Figure11)
This is a description of a medication called Gabapentin manufactured by Laurus Generics Inc. Each capsule contains 400 mg of Gabapentin USP and the product is sold in a bottle containing 30 capsules. There is a package insert with detailed prescribing information and medication guide to be provided to each patient when dispensing the medication, which should be dispensed in child-resistant containers. The medication should be stored at temperatures between 20-25°C (68-77°F) with excursions between 15-30°C (59-86°F) allowed.*
FDA Label Image

Figure-12 (Gabapentin Figure12)

Figure-12 (Gabapentin Figure12)
This seems to be a product label for Gabapentin Capsule, USP, manufactured by Laurus Labs Limited, and the label contains information about the product such as Lot number and Expiration date.*
FDA Label Image

Figure13 (Gabapentin Figure13)

Figure13 (Gabapentin Figure13)
This is a description of Gabapentin Capsules manufactured by Laurus Generics Inc. The National Drug Code for this medication is 42385-974-72, and each capsule contains 400 mg of Gabapentin USP. The medication guide should be dispensed to each patient and this is for institutional use only. It comes in a box of 100 (10x10) Unit-Dose Capsules Rx Only, and dosage and use instructions should be obtained from the package insert. It should be stored at temperatures between 20°C to 25°C (68°F to 77°F) but excursions are allowed between 15°C to 30°C (59°F to 86°F). This medication is manufactured by Laurus Labs in India and distributed by Laurus Generics in Berkeley Heights, NJ, USA.*
FDA Label Image

Figure 2 (Gabapentin Figure2)

Figure 2 (Gabapentin Figure2)
This appears to be a chart or graph that shows the mean pain score during a 3-week dose titration period followed by a 4-week fixed dose period. The scores are compared between a placebo and two doses of gabapentin - 1800 mg/day and 2400 mg/day. The chart also shows a baseline week and multiple weeks of the study.*
FDA Label Image

Figure 3 (Gabapentin Figure3)

Figure 3 (Gabapentin Figure3)
The text provides a chart which shows the proportion of responders, patients with a 50% reduction in pain score in controlled PHN studies. It includes percentages from 100% to 0%. Additionally, it shows study information such as study and study 2. The text also includes statistical data with p-values and currency values for different drugs, including PBO, GBP 3600, GBP 1800, and GBP 2400.*
FDA Label Image

Figure 1 (Gabapentin Figure4)

FDA Label Image

Figure5 (Gabapentin Figure5)

FDA Label Image

Figure-6 (Gabapentin Figure6)

Figure-6 (Gabapentin Figure6)
This is a description of a medication called Gabapentin Capsule, USP. The manufacturer of the medicine is Laurus Labs Limited and the NDC code is 42385.972-17. The lot and expiration dates are not provided. The text also includes some illegible characters and symbols, making it difficult to provide a complete and accurate description.*
FDA Label Image

Figure7 (Gabapentin Figure7)

Figure7 (Gabapentin Figure7)
This is a description of a medicine product named "Gabapentin Capsules, USP". The NDC number assigned to it is 42385.972:72. Each capsule contains 100 mg of gabapentin USP. The enclosed medication guide should be given to each patient. The dosage and use of this medicine are described in the package insert. It should be stored at temperatures between 20° to 25°C. The product is made by Laurus Generics Inc. and manufactured by Laurus Labs Limited in India. The text also includes a unique number "M. L No.: 16/VSP/AP/2015/F&BICC".*
FDA Label Image

Figure8 (Gabapentin Figure8)

Figure8 (Gabapentin Figure8)
Each capsule contains 300 mg of gabapentin USP. NDC 42385-973-30. Gabapentin capsules, USP. Dispense the enclosed medication guide to each patient. Dosage and use: See package insert for full prescribing information. Dispense in tight (USP), child-resistant containers. Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F). [See USP Controlled Room Temperature.] Manufactured for: Laurus Generics Inc. 400 Connell Drive Suite 5200 Berkeley Heights, NJ 07922. Manufactured by: Laurus Labs Limited Anakapalli-531011 India. M. L. No.: 16/VSP/AP/2015/F&B/CC.*
FDA Label Image

Figure9 (Gabapentin Figure9)

Figure9 (Gabapentin Figure9)
This is a description of Gabapentin Capsule, USP manufactured by Laurus Labs Limited with a NDC code of 42385-97317, and a Lot number and expiration date that are not available. The prescription drug is often prescribed for the treatment of epilepsy, neuropathic pain, and restless leg syndrome. The text includes repeated information, but no specific information about dosage, indications, or side effects.*
FDA Label Image

Structure (Gabapentin Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.